150 related articles for article (PubMed ID: 9756510)
1. Reduced folate derivatives are endogenous substrates for cMOAT in rats.
Kusuhara H; Han YH; Shimoda M; Kokue E; Suzuki H; Sugiyama Y
Am J Physiol; 1998 Oct; 275(4):G789-96. PubMed ID: 9756510
[TBL] [Abstract][Full Text] [Related]
2. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR).
Ishizuka H; Konno K; Naganuma H; Sasahara K; Kawahara Y; Niinuma K; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1304-11. PubMed ID: 9067317
[TBL] [Abstract][Full Text] [Related]
3. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.
Sasabe H; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2,4-dinitrophenyl)-glutathione and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole glucuronide.
Niinuma K; Takenaka O; Horie T; Kobayashi K; Kato Y; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Aug; 282(2):866-72. PubMed ID: 9262353
[TBL] [Abstract][Full Text] [Related]
5. Biliary excretion of 17beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2.
Morikawa A; Goto Y; Suzuki H; Hirohashi T; Sugiyama Y
Pharm Res; 2000 May; 17(5):546-52. PubMed ID: 10888306
[TBL] [Abstract][Full Text] [Related]
6. Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan.
Nishino A; Kato Y; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2000 Oct; 28(10):1146-8. PubMed ID: 10997931
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats.
Masuda M; I'izuka Y; Yamazaki M; Nishigaki R; Kato Y; Ni'inuma K; Suzuki H; Sugiyama Y
Cancer Res; 1997 Aug; 57(16):3506-10. PubMed ID: 9270020
[TBL] [Abstract][Full Text] [Related]
8. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter.
Yamazaki M; Akiyama S; Ni'inuma K; Nishigaki R; Sugiyama Y
Drug Metab Dispos; 1997 Oct; 25(10):1123-9. PubMed ID: 9321514
[TBL] [Abstract][Full Text] [Related]
9. Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats.
Gotoh Y; Suzuki H; Kinoshita S; Hirohashi T; Kato Y; Sugiyama Y
J Pharmacol Exp Ther; 2000 Jan; 292(1):433-9. PubMed ID: 10604980
[TBL] [Abstract][Full Text] [Related]
10. Primary active transport of peptidic endothelin antagonists by rat hepatic canalicular membrane.
Akhteruzzaman S; Kato Y; Hisaka A; Sugiyama Y
J Pharmacol Exp Ther; 1999 Feb; 288(2):575-81. PubMed ID: 9918561
[TBL] [Abstract][Full Text] [Related]
11. Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats.
Chu XY; Kato Y; Niinuma K; Sudo KI; Hakusui H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Apr; 281(1):304-14. PubMed ID: 9103511
[TBL] [Abstract][Full Text] [Related]
12. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats.
Hirohashi T; Suzuki H; Ito K; Ogawa K; Kume K; Shimizu T; Sugiyama Y
Mol Pharmacol; 1998 Jun; 53(6):1068-75. PubMed ID: 9614210
[TBL] [Abstract][Full Text] [Related]
13. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
Han YH; Kato Y; Watanabe Y; Terao K; Asoh Y; Sugiyama Y
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322
[TBL] [Abstract][Full Text] [Related]
14. Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats.
Fernández-Checa JC; Takikawa H; Horie T; Ookhtens M; Kaplowitz N
J Biol Chem; 1992 Jan; 267(3):1667-73. PubMed ID: 1730711
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR.
Ito K; Suzuki H; Hirohashi T; Kume K; Shimizu T; Sugiyama Y
Am J Physiol; 1997 Jan; 272(1 Pt 1):G16-22. PubMed ID: 9038871
[TBL] [Abstract][Full Text] [Related]
16. Enterohepatic circulation kinetics of bile-active folate derivatives and folate homeostasis in rats.
Shin HC; Takakuwa F; Shimoda M; Kokue E
Am J Physiol; 1995 Aug; 269(2 Pt 2):R421-5. PubMed ID: 7653665
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective hepatobiliary transport of the quinolone antibiotic grepafloxacin and its glucuronide in the rat.
Sasabe H; Kato Y; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 1998 Feb; 284(2):661-8. PubMed ID: 9454812
[TBL] [Abstract][Full Text] [Related]
18. Identification of 10-formyltetrahydrofolate, tetrahydrofolate and 5-methyltetrahydrofolate as major reduced folate derivatives in rat bile.
Shin HC; Shimoda M; Kokue E; Takahashi Y
J Chromatogr; 1993 Oct; 620(1):39-46. PubMed ID: 8106590
[TBL] [Abstract][Full Text] [Related]
19. Determination of folate transport pathways in cultured rat proximal tubule cells.
Sikka PK; McMartin KE
Chem Biol Interact; 1998 Jul; 114(1-2):15-31. PubMed ID: 9744553
[TBL] [Abstract][Full Text] [Related]
20. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.
Paulusma CC; van Geer MA; Evers R; Heijn M; Ottenhoff R; Borst P; Oude Elferink RP
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):393-401. PubMed ID: 10024515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
